Acetylcysteine for Contrast-Induced Nephropathy Trial - ACT

Description:

The goal of the trial was to evaluate treatment with acetylcysteine compared with placebo among patients at risk for contrast-induced nephropathy (CIN) undergoing an angiographic procedure.